Amsterdam Live Endoscopy, NetherlandsThe fifth edition of the Amsterdam Live Endoscopy congress will provide quality endoscopy teaching for doctors and nurses with state-of-the-art lectures, small-scale tips & tricks sessions and live demonstrations of common and high-end, diagnostic and therapeutic gastrointestinal endoscopy. For more information visit the Amsterdam Endoscopy website: http://www.amsterdamendoscopy.com/
Advanced Diagnostic & Therapeutic Endoscopy Course, Boston, Massachusetts, USAConfocal Endomicroscopy will be prominently featured and discussed at this upcoming Harvard Medical School course directed by Dr William Brugge and Dr John Saltzman. Diagnostic features of endoscopic confocal endomicroscopy in the GI tract will be shown.
Video Digest, Paris, FranceThis year's Video Digest, hosted by the SFED, will include a rich variety of workshops, live demonstrations, and an interactive session with clinical cases and a quiz. For more information visit the SFED website: http://www.sfed.org/Video-Digest/
UEGW 2011, Stockholm, SwedenSee the latest presentations on Cellvizio at UEGW, the 19th United European Gastroenterology Week Oct.22-26, 2011 in Stockholm.
Annual Update on Gastrointestinal Cancers, New York, NY, USAAnnual Update on Gastrointestinal Cancers: The clinical information provided in this course will assist gastroenterologists, surgeons, medical oncologists, radiation oncologists, and others in maximizing their participation in the multidisciplinary approach to care and, ultimately, in optimizing care and outcomes for individuals who require preventive, diagnostic, and/or therapeutic services for a GI cancer.
4th Annual Gastroenterology & Hepatology Symposium, Las Vegas, Nevada, USA4th Annual Gastroenterology & Hepatology Symposium: This continuing medical education (CME) program will provide, through formal lectures and question-and answer sessions, updates on new approaches in the diagnosis and management of gastrointestinal and liver diseases.
Surgery and the Management of Esophageal Cancer, Pittsburgh, Pennsylvania, USASurgery and the Management of Esophageal Cancer: This postgraduate course highlights the indications, outcomes and technical aspects of esophagectomy, with a focus on minimally invasive techniques. The program will consist of a series of lectures as well as live case demonstrations.
APDW, SingaporeAPDW2011 will be held in Singapore from 1 to 4 October 2011. Themed “Integrating Science and Technology in Clinical Gastroenterology”, the Congress features various international expert speakers who will provide great insights into the latest industry trends.
Cellvizio featured in 9news.com : World's smallest microscope finds cancer fasterSt. Anthony Hospital is the first hospital in Colorado to use the new advanced-imaging technology, called Cellvizio, with at-risk patients during standard endoscopy and colonoscopy procedures as well as the pancreatic and bile duct cancer detection procedure. Cellvizio allows physicians to view internal tissues cell-by-cell to pinpoint cancerous and pre-cancerous tissue more efficiently than current procedures. Dr. Matt Reveille says the new technology helps doctors respond once they identify dangerous tissue.
Cellvizio in the Sioux Falls Business JournalFantastic article by Sanford Hospital in the Sioux Falls Business Journal. "This can change the practice of medicine,” said Dr. Muslim Atiq, a gastroenterologist at Sanford. “The whole key is to find cancer before cancer occurs. To find it very early makes a big difference.”
CELLVIZIO DAY : TRAINING WORKSHOP AT PAOLI CALMETTES INSTITUTE - MARSEILLE, FRANCEAcquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
Cellvizio News, May 2013FDA grants Mauna Kea Technologies 510(k) clearance to market AQ-Flex™19 miniprobe for fine needle aspiration procedures Mauna Kea Technologies announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ‐Flex™ 19 miniprobe to provide real‐time optical biopsies during endoscopic ultrasound‐guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio on one of its dedicated miniprobes, which already obtained the CE mark in Europe.
MAUNA KEA TECHNOLOGIES ENTERS INTO MAJOR CELLVIZIO® DISTRIBUTION AGREEMENT WITH A LEADING JAPANESE MEDICAL DEVICE COMPANYPARIS, (June 13, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported that it has entered an exclusive distribution agreement in Japan with AMCO Inc. for a five-year period. This partnership further strengthens Mauna Kea Technologies’ ties with the Japanese market, and is a major step forward in the company’s efforts to obtain regulatory approval in the world’s second largest endoscopy device market after the US. The Japanese Ministry of Health, Labor, and Welfare (MHLW) requires foreign medical device companies to have a physical presence within the country or define a partnering distributor prior to approving a device for commercial sale.